Emergency Use Authorization will be submitted to the FDA in days for a COVID-19 vaccine developed by Pfizer and BioNTech

Pfizer and BioNTech have announced their large Phase 3 COVID-19 vaccine trial is complete. The trial has reportedly met all its primary endpoints and the vaccine is claimed to be 95 percent effective.

Continue Reading

Category: Health & Wellbeing, Lifestyle

Tags: , , ,